A Phase 3 Narcolepsy Clinical Trial Has Completed Enrollment
According to a story from Biotech 365, the biopharmaceutical company Avadel Pharmaceuticals plc recently announced that it has completed enrollment for its phase 3 clinical trial. This trial will test…